Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors

Annals of Allergy, Asthma and Immunology

Volumn 89, Issue 1, 2002, Pages 90-98

  Fujiu, Toru ^a   Kato, Masahiko ^a   Kimura, Hirokazu ^b   Tachibana, Atsushi ^a   Suzuki, Masato ^a   Nako, Yasushi ^a   Morikawa, Akihiro ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C5A; EOSINOPHIL PROTEIN X; EOTAXIN; G PROTEIN COUPLED RECEPTOR; LEUKOTRIENE B4; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CELL ADHESION; CHEMOLUMINESCENCE; DEGRANULATION; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEASUREMENT; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0036666658     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61917-5     Document Type: Article

References (42)

1. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990;85:422-436.
2. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
3. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
4. Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2144-2148.
5. Dobrina A, Menegazzi R, Carlos TM, et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J Clin Invest 1991;88:20-26.
6. Bochner BS, Luscinskas FW, Gimbrone MA Jr, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173: 1553-1557.
7. Ebisawa M, Bochne BS, Georas SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 β-induced transendothelial migration. J Immunol 1992;149:4021-4028.
8. Moser R, Fehr J, Olgiati L, Bruijnzeel PL. Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood 1992;79:2937-2945.
9. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663.
10. Nagy L, Lee TH, Goetzl EJ, et al. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol 1982;47:541-547.
11. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986;78:1701-1706.
12. Jose PJ, Griffiths-Ohnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airway inflammation. J Exp Med 1994;179:881-887.
13. Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-612.
14. Kroegel C, Yukawa T, Dent G, et al. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989;142:3518-3526.
15. Kroegel C, Yukawa T, Dent G, et al. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils. Immunology 1988;64:559-561.
16. Abu-Ghazaleh RI, Kita H, Gleich GJ. Eosinophil activation and function in health and disease. Immunol Ser 1992;57:137-167.
17. Honda Z, Nakanura M, Miki I, et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 1991;349:342-346.
18. Nakanura M, Honda Z, Izumi T, et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 1991;266:20400-20405.
19. Gerard NP, Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991;349:614-619.
20. Kitaura M, Nakajima T, Imai T, et al. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 1996;271:7725-7730.
21. Daugherty BL, Siciliano SJ, DeMartino JA, et al. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996;183:2349-2354.
22. Yokomizo T, Izumi T, Chang K, et al. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 1997;387:620-624.
23. Horie S, Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet- activating factor. J Immunol 1994;152:5457-5467.
24. 2 integrin in the activation of eosinophils stimulated by IgG. J Immunol 1995;155:2631-2641.
25. 2 integrin triggers activation and degranulation of human eosinophils. Am J Respir Cell Mol Biol 1998;18:675-686.
26. Nakano M. Determination of superoxide radical and singlet oxygen based on chemiluminescence of luciferin analogs. Methods Enzymol 1990;186:585-591.
27. Kato M, Tokuyama K, Morikawa A, et al. Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs. Eur J Pharmacol 1993;232:7-12.
28. Ide M, Weiler D, Kita H, Gleich GJ. Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival. J Immunol Methods 1994;168:187-196.
29. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, et al. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-2400.
30. Lub M, van Kooyk Y, Figdor CG. Ins and outs of LFA-1. Immunol Today 1995;16:479-483.
31. 2+ modulates leukocyte function-associated antigen-1 cell surface distribution on T lymphocytes and consequently affects cell adhesion. J Cell Biol 1994;124:1061-1070.
32. Graham IL, Brown EJ. Extracellular calcium results in a conformational change in Mac-1 (CD11b/CD18) on neutrophils. Differentiation of adhesion and phagocytosis functions of Mac-1. J Immunol 1991;146:685-691.
33. Morita E, Schroder JM, Christophers E. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand J Immunol 1989;29:709-716.
34. Erger RA, Casale TB. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator. Am J Respir Cell Mol Biol 1995;12:65-70.
35. Nabe T, Yamamura H, Kohno S. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro. Arzneimittelforschung 1997;47:1112-1116.
36. 2+-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 1996;88:3195-3199.
37. El Shazly A, Masuyama K, Nakano K, et al. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. Int Arch Allergy Immunol 1998;117:55-58.
38. Freyer DR, Boxer LA, Axtell RA, Todd RF 3d. Stimulation of human neutrophil adhesive properties by adenine nucleotides. J Immunol 1988;141:580-586.
39. Sanmugalingham D, De Vries E, Gauntlett R, et al. Interleukin-5 enhances eosinophil adhesion to bronchial epithelial cells. Clin Exp Allergy 2000;30:255-263.
40. Burke-Gaffney A, Hellewell PG. A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. Am J Respir Cell Mol Biol 1998;19:408-418.
41. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989;341:197-205.
42. 2. Int Arch Allergy Immunol 1999;120(Suppl):51-53.